Trials / Sponsors / Opus Genetics, Inc
Opus Genetics, Inc
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystroph ARB, BVMD, Autosomal-Dominant Bestrophinopathy | Phase 1 / Phase 2 | 2025-09-25 |
| Recruiting | Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and LCA5 | Phase 1 / Phase 2 | 2023-06-15 |